SERA PROGNOSTICS, INC. Current Assets
SERA PROGNOSTICS, INC. (SERA) had Current Assets of $48.13 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $48.13M.
- 2026-03-31: Assets, Current $49.73M.
- 2025-12-31: Assets, Current $40.77M.
- 2025-09-30: Assets, Current $44.49M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $48.13M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $49.73M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $40.77M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $44.49M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $40.87M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $47.28M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $47.60M 10-K · filed 2026-03-18 |
| 2024-09-30 | $51.11M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $51.54M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $53.85M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $61.34M 10-K · filed 2025-03-19 |
| 2023-09-30 | $47.55M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $64.43M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $72.11M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $90.13M 10-K · filed 2024-03-20 |
| 2022-09-30 | $90.84M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $108.05M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $109.47M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $110.25M 10-K · filed 2023-03-22 |
| 2021-09-30 | $122.34M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $91.37M 10-Q · filed 2021-08-30 |
| 2020-12-31 | $13.73M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |